After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Intellia Therapeutics Inc is $1.07B. A total of 6.58 million shares were traded on the day, compared to an average of 7.45M shares.
In the most recent transaction, LEONARD JOHN M sold 88,146 shares of NTLA for 9.49 per share on Dec 11 ’25. After the transaction, the President and CEO now owns 1,038,928 company shares. In a previous transaction on Dec 11 ’25, LEONARD JOHN M bought 88,146 shares at 9.33 per share.
Among the insiders who sold shares, Schultes Birgit C disposed of 31 shares on Oct 01 ’25 at a per-share price of $17.38. This resulted in the EVP, Chief Scientific Officer holding 105,184 shares of NTLA after the transaction. In another insider transaction, Dube Michael P sold 1,871 shares at $17.38 per share on Oct 01 ’25. Company shares held by the VP, Chief Accounting Officer now total 55,266.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, NTLA has a high of $28.25 and a low of $5.90.
As of this writing, NTLA has an earnings estimate of -$0.97 per share for the current quarter. EPS was calculated based on a consensus of 19.0 estimates, with a high estimate of -$0.81 per share and a lower estimate of -$1.1. The company reported an EPS of -$1.27 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. NTLA’s latest balance sheet shows that the firm has $748.69M in Cash & Short Term Investments as of fiscal 2021. There were $74.02M in debt and $125.83M in liabilities at the time. Its Book Value Per Share was $6.46, while its Total Shareholder’s Equity was $1.04B.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NTLA is Buy with a score of 3.69.
